Skip to main content
. 2011 Sep 20;15(5):R220. doi: 10.1186/cc10457

Table 1.

Linear mixed model on the mean (95% confidence interval) changes in mHLA-DR at every measure point in the survivor and non-survivor groups

Day 0 Day 3 Day 7
Number mHLA-DR Number mHLA-DR Number mHLA-DR ΔmHLA-DR3 ΔmHLA-DR7 ΔmHLA-DR7-3

Survivor 56 62.97
(56.38~69.55)
56 69.42
(62.92~75.92)
56 79.87
(73.96~85.78)
6.45a
(2.50~10.40)
16.90b
(11.85~21.95)
10.45c
(6.19~14.71)
Non-survivor 23 56.77
(46.49~67.05)
16 55.08
(44.26~65.90)
10 61.32
(49.79~72.84)
-1.69d
(-8.95~5.57)
4.55e
(-5.96~15.06)
6.24f
(-3.28~15.76)
Between-
groups difference
8.14g
(-0.12~16.40)
12.35h
(0.70~24.00)
4.21i
(-6.21~14.64)

ΔmHLA-DR3 and ΔmHLA-DR7 were defined as the value change in mHLA-DR on days 3 and 7 compared with that on day 0, and ΔmHLA-DR7-3 was defined as the value change in mHLA-DR on day 7 compared with that on day 3. In the comparison of mean mHLA-DR differences in the same group between every measurement point, P values were a0.002, b < 0.001, c < 0.001, d0.644, e0.392, and f0.195. In the comparison of ΔmHLA-DR differences between two groups within the same measurement point, P values were g0.053, h0.038, and i0.423. CI, confidence interval; mHLA-DR, monocyte human leukocyte antigen-DR.